TY - JOUR A1 - Gerber, Markus A1 - Ehrbar, Janine A1 - Brand, Ralf A1 - Antoniewicz, Franziska A1 - Brand, Serge A1 - Colledge, Flora A1 - Donath, Lars A1 - Egger, Stephan T. A1 - Hatzinger, Martin A1 - Holsboer-Trachsler, Edith A1 - Imboden, Christian A1 - Schweinfurth, Nina A1 - Vetter, Stefan A1 - Ludyga, Sebastian T1 - Implicit attitudes towards exercise and physical activity behaviour among in-patients with psychiatric disorders JF - Mental Health and Physical Activity N2 - The current body of evidence suggests that in healthy participants, implicit attitudes towards physical activity explain variance in exercise behaviour beyond explicit cognitive processes. However, such relationships have not been examined in psychiatric patients, although this may contribute to a better understanding of the motivational and volitional resources needed to self-regulate their exercise behaviour. Therefore, the present cross-sectional study aimed to assess implicit attitudes towards exercise among psychiatric in-patients, and to correlate these implicit attitudes with their physical activity levels. Patients (N = 101) showing a psychiatric disorder, but no severe cognitive impairment, were directly recruited from psychiatric clinics. Their physical activity levels were assessed using both accelerometers and self-reports. Additionally, patients reported psychiatric symptoms and performed a single-target implicit association test (ST-IAT) with exercise employed as the target category. Of all patients, 39% showed a preference for exercise, whereas 13% showed an aversion towards exercise. The implicit attitudes of the remaining participants were equally strong for both concepts. Based on correlational analysis (correcting for age, sex, psychiatric symptoms severity, and ST-IAT sequence), no association was found between ST-IAT score, or self-reported and objectively assessed physical activity. Consequently, the link between exercise behaviour and implicit attitudes towards physical activity found in healthy participants could not be observed in psychiatric patients. KW - Accelerometry KW - Automatic evaluation KW - Dual mode theory KW - Physical activity Y1 - 2018 U6 - https://doi.org/10.1016/j.mhpa.2018.08.001 SN - 1755-2966 VL - 15 SP - 71 EP - 77 PB - Elsevier CY - Oxford ER - TY - BOOK A1 - Holtmann, Dieter A1 - Mutz, Michael A1 - Alber, Florian A1 - Görl, Tilo A1 - Buchheister, Claudia A1 - Hinteregger, Sigrid A1 - Grüneberg, Franziska A1 - Meisdrock, Claudia A1 - Jeske, Lydia A1 - Ratzlaff, Olaf A1 - Arlt, Maria A1 - Fink, Jana A1 - Wille, Robin A1 - Steinberg, Juliane A1 - Fütterer, Bernhard A1 - Balke, Gregor A1 - Wache, Stephan A1 - Benz, Caroline A1 - Humcke, Daniela A1 - Bruhn, Anja A1 - Lapp, Joachim A1 - Buhr, Stefanie A1 - Zippka, Susanne A1 - Thessel, Friedericke T1 - Zur Performanz von Wohlfahrtsregimen und zu den Unterstützungspotentialen für die verschiedenen Wohlfahrtskonzepte N2 - Wie Gesellschaften Wohlfahrt organisieren und institutionalisieren, drückt ihre grundlegenden Wertvorstellungen über gutes Zusammenleben aus. Der Vergleich von Gesellschaften lässt sich besonders fruchtbar mit dem Konzept der Wohlfahrtsregime durchführen, das die Logiken der Produktion und Verteilung von Wohlfahrt ins Zentrum stellt und mit dem Regimebegriff die zeitliche Entwicklung durch Regierungsphasen mit einer bestimmten politischen Ausrichtung thematisiert. Deshalb werden aufgrund einer Auseinandersetzung mit der sozialphilosophischen Diskussion acht Performanzkriterien entwickelt, die als Maßstab für den Vergleich von 28 Ländern und fünf Wohlfahrtsregimen verwendet werden: Wohlstand und Wachstum; ökologische Nachhaltigkeit; Innovation; soziale Sicherung durch Unterstützungsleistungen im Risikofall sowie vorsorgend durch Bildungsinvestitionen; Anerkennung der Besonderheiten (Frauenfreundlichkeit und Migrantenfreundlichkeit); Gleichheit der Teilhabe; soziale Integration; Autonomie („freedom of choice and capabilities”). Anschließend wird der Umbau der Wohlfahrtsregime anlässlich der aktuellen Herausforderungen und Randbedingungen für die verschiedenen Wohlfahrtsregime diskutiert. Schließlich wird untersucht, welche Gruppen in welchen Ländern welche der sechs Wohlfahrtskonzepte unterstützen, die sich bei der Faktorenanalyse von internationalen Einstellungssurveys ergeben. Y1 - 2006 SN - 3-939469-31-9 SN - 978-3-939469-31-5 PB - Univ.-Verl. CY - Potsdam ER - TY - JOUR A1 - Obrig, Hellmuth A1 - Mock, Julia A1 - Stephan, Franziska A1 - Richter, Maria A1 - Vignotto, Micol A1 - Rossi, Sonja T1 - Impact of associative word learning on phonotactic processing in 6-month-old infants: A combined EEG and fNIRS study JF - Developmental cognitive neuroscience : a journal for cognitive, affective and social developmental neuroscience KW - fNIRS KW - Phonotactics KW - Associative training KW - Language development Y1 - 2017 U6 - https://doi.org/10.1016/j.dcn.2016.09.001 SN - 1878-9293 SN - 1878-9307 VL - 25 SP - 185 EP - 197 PB - Elsevier CY - Oxford ER - TY - JOUR A1 - Müller, Sandra Marie A1 - Ebert, Franziska A1 - Raber, Georg A1 - Meyer, Sören A1 - Bornhorst, Julia A1 - Hüwel, Stephan A1 - Galla, Hans-Joachim A1 - Francesconi, Kevin A. A1 - Schwerdtle, Tanja T1 - Effects of arsenolipids on in vitro blood-brain barrier model JF - Archives of toxicology : official journal of EUROTOX N2 - Arsenic-containing hydrocarbons (AsHCs), a subgroup of arsenolipids (AsLs) occurring in fish and edible algae, possess a substantial neurotoxic potential in fully differentiated human brain cells. Previous in vivo studies indicating that AsHCs cross the blood–brain barrier of the fruit fly Drosophila melanogaster raised the question whether AsLs could also cross the vertebrate blood–brain barrier (BBB). In the present study, we investigated the impact of several representatives of AsLs (AsHC 332, AsHC 360, AsHC 444, and two arsenic-containing fatty acids, AsFA 362 and AsFA 388) as well as of their metabolites (thio/oxo-dimethylpropionic acid, dimethylarsinic acid) on porcine brain capillary endothelial cells (PBCECs, in vitro model for the blood–brain barrier). AsHCs exerted the strongest cytotoxic effects of all investigated arsenicals as they were up to fivefold more potent than the toxic reference species arsenite (iAsIII). In our in vitro BBB-model, we observed a slight transfer of AsHC 332 across the BBB after 6 h at concentrations that do not affect the barrier integrity. Furthermore, incubation with AsHCs for 72 h led to a disruption of the barrier at sub-cytotoxic concentrations. The subsequent immunocytochemical staining of three tight junction proteins revealed a significant impact on the cell membrane. Because AsHCs enhance the permeability of the in vitro blood–brain barrier, a similar behavior in an in vivo system cannot be excluded. Consequently, AsHCs might facilitate the transfer of accompanying foodborne toxicants into the brain. KW - Arsenolipids KW - Arsenic-containing hydrocarbons KW - Arsenic-containing fatty acids KW - In vitro blood-brain barrier model Y1 - 2017 SN - 0340-5761 SN - 1432-0738 VL - 92 IS - 2 SP - 823 EP - 832 PB - Springer CY - Heidelberg ER - TY - JOUR A1 - Klann-Delius, Gisela A1 - Kauschke, Christina A1 - Glück, Christian W. A1 - Schröder, Astrid A1 - Lorenz, Antje A1 - Domahs, Frank A1 - Grande, Marion A1 - Domahs, Ulrike A1 - Frankenberg, Jenny v. A1 - Wahl, Michael A1 - De Kok, Dörte A1 - Stadie, Nicole A1 - Machleb, Franziska A1 - Manz, Katrin A1 - Frank, Ulrike A1 - Sperlich, Kathrin A1 - Vauth, Friederike A1 - Hampel, Pamela A1 - Mäder, Mark A1 - Sticher, Heike A1 - Bethmann, Anja A1 - Fischenich, Andrea A1 - Scheich, Henning A1 - Brechmann, André A1 - Peschke, Claudia A1 - Ziegler, Wolfram A1 - Kappes, Juliane A1 - Baumgärtner, Annette A1 - Sonntag, Kristin A1 - Bartels, Luise A1 - Heide, Judith A1 - Meinunger, André A1 - Burchert, Frank A1 - Bohn, Christiane A1 - Kliegl, Reinhold A1 - Gottal, Stephanie A1 - Berendes, Karin A1 - Grabherr, Britta A1 - Schneeberg, Jennifer A1 - Wittler, Marion A1 - Ptok, Martin A1 - Sallat, Stephan ED - Wahl, Michael ED - Michael, Judith ED - Hanne, Sandra T1 - Spektrum Patholinguistik = Schwerpunktthema: der Erwerb von Lexikon und Semantik: Meilensteine, Störungen und Therapie ; Tagungsband zum 1. Herbsttreffen Patholinguistik, 24. November 2007 N2 - Der vorliegende Tagungsband enthält alle Beiträge des 1. Herbsttreffens Patholinguistik, das am 24.11.2007 an der Universität Potsdam stattgefunden hat. Sowohl die drei Hauptvorträge zum Thema „Der Erwerb von Lexikon und Semantik – Meilensteine, Störungen und Therapie“ als auch die Kurzvorträge promovierter Patholinguisten sind ausführlich dokumentiert. Außerdem enthält der Tagungsband die Abstracts der präsentierten Poster. N2 - These proceedings contain the contributions presented at the “1st Herbsttreffen Patholinguistik” that took place on November 24, 2007 at the University of Potsdam. Three main lectures focused on "The acquisition of lexicon and semantics - milestones, impairments, and intervention". In addition, the proceedings contain short presentations on patholinguistic research and the abstracts of the presented posters. T3 - Spektrum Patholinguistik - 1 KW - Patholinguistik KW - Spracherwerb KW - Sprachtherapie KW - lexikalisch-semantische Störungen KW - Sprachentwicklungsstörung (SES) KW - patholinguistics KW - language acquisition KW - speech and language therapy KW - impairments of lexicon and semantics KW - specific language impairment (SLI) Y1 - 2008 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:kobv:517-opus-18688 SN - 1869-3822 SN - 1866-9433 IS - 1 PB - Universitätsverlag Potsdam CY - Potsdam ER -